Evidence map›Paper›PMID 22695395›Full record

ReviewNature reviews. Cancer2012

Developmental reprogramming of cancer susceptibility.

Cheryl Lyn Walker, Shuk-mei Ho

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 153 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Endocrine Disruptor Chemicals and Children's Health.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Hypermethylation ofEXCLI journal · 2022
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Cheryl Lyn WalkerInstitute of Biosciences and Technology, Texas A&M Health Science Center, 2121 W. Holcombe Boulevard, Houston, TX 77030, USA. cwalker@ibt.tamhsc.edu
Shuk-mei Ho
Texas A&M Health Science Center · USUniversity of Cincinnati · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
ENVIRONMENTAL ESTROGENS AND UTERINE LEIOMYOMAR01ES008263 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WALKER, CHERYL L. · 1996 to 2012
$3.8M
Epigenetic Basis for Prostate Carcinogenesis following Early Estrogenic ExposuresR01ES015584 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HO, SHUK-MEI, PRINS, GAIL S · 2008 to 2012
$3.1M
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer RiskU01ES019480 · NIEHS · UNIVERSITY OF CINCINNATI · PI HO, SHUK-MEI · 2010 to 2014
$2.2M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WALKER, CHERYL L. · 2009 to 2010
$1.9M
Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer SusceptiRC2ES018758 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HO, SHUK-MEI, PRINS, GAIL S · 2009 to 2010
$1.9M
Reversing the Effects of Developmental ReprogrammingR21ES020055 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WALKER, CHERYL L. · 2011 to 2012
$420k
G-protein coupled receptor-30(GPR30):a putative new therapeutic target for PCaI01BX000675 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI HO, SHUK-MEI · 2011 to 2019
–
BLRD VA I01 BX000675NIEHS NIH HHS ES008263NIEHS NIH HHS ES018789NIEHS NIH HHS ES020055NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P30ES006096NIEHS NIH HHS R01 ES008263NIEHS NIH HHS R01 ES015584NIEHS NIH HHS R01ES015584NIEHS NIH HHS R21 ES020055NIEHS NIH HHS RC2 ES018758NIEHS NIH HHS RC2ES018758NIEHS NIH HHS RC2 ES018789NIEHS NIH HHS RC2ES018789NIEHS NIH HHS U01 ES019480NIEHS NIH HHS U01ES019480
6 · The paper itself

Abstract

Gene-environment interactions have been traditionally understood to promote the acquisition of mutations that drive multistage carcinogenesis, and, in the case of inherited defects in tumour suppressor genes, additional mutations are required for cancer development. However, the developmental origins of health and disease (DOHAD) hypothesis provides an alternative model whereby environmental exposures during development increase susceptibility to cancer in adulthood, not by inducing genetic mutations, but by reprogramming the epigenome. We hypothesize that this epigenetic reprogramming functions as a new type of gene-environment interaction by which environmental exposures target the epigenome to increase cancer susceptibility.

Indexed as

Gene-Environment InteractionDisease SusceptibilityEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticHumansPregnancyPrenatal Exposure Delayed Effects

Identifiers

PMID22695395
PMCPMC3820510
OpenAlexW2048676725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.